NN

Nanjesh Niranjan Swamy

Active Director Director DIN 07243013
DIN 07243013 First appointment Aug 2015 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 4 active board seats
Past companies 1 historical roles
Total affiliations 5 Since Aug 2015
Shareholding value •••• Premium profile

About Nanjesh Niranjan Swamy

Data last updated:

Nanjesh Niranjan Swamy is a Director at Behandeln Medcare Solutions Private Limited (since 2015), Managing Director at Attentionkart Private Limited (since 2022) and Director at Happicare Curated Health Private Limited (since 2023), and holds 1 more current directorship. The companies operate in Healthcare, Information Technology and Education & Learing. The 2 current companies with reported revenue have a combined latest revenue of ₹4.66 Cr; the largest is Behandeln Medcare Solutions Private Limited at ₹4.65 Cr (FY 2020). Earlier, Nanjesh Niranjan Swamy was a Designated Partner at Enkefalos Technologies Llp (2020–2023).

DIN 07243013
Primary Designation Director
Industry Healthcare
First Appointment 25 Aug 2015
Oldest Company Age 11 yrs
Largest company Behandeln Medcare Solutions Private Limited · ₹4.65 Cr (FY 2020)
Combined revenue ₹4.66 Cr across 2 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director25 Aug 20152015₹4.65 Cr (FY 2020)Active
Attentionkart Private Limited U72900KA2022PTC163188
Managing Director30 Jun 20222022₹1.3 Lakh (FY 2025)Active
Director02 Jun 20232023Active
Designated Partner07 May 20212021Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner21 Oct 20202020₹4.08 Cr (FY 2025)Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Attentionkart Technologies Llp
Attentionkart Private Limited
Behandeln Medcare Solutions Private Limited
Happicare Curated Health Private Limited
Premium access

Shareholding and investment profile for Nanjesh Niranjan Swamy

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Nanjesh Niranjan Swamy

Nanjesh Niranjan Swamy currently holds 4 directorships: Behandeln Medcare Solutions Private Limited (Director, since 25 Aug 2015, revenue ₹4.65 Cr (FY 2020)); Attentionkart Private Limited (Managing Director, since 30 Jun 2022, revenue ₹1.3 Lakh (FY 2025)); Happicare Curated Health Private Limited (Director, since 02 Jun 2023); Attentionkart Technologies Llp (Designated Partner, since 07 May 2021).

Nanjesh Niranjan Swamy was first appointed on 25 Aug 2015 as Director at Behandeln Medcare Solutions Private Limited. The most recent appointment on record is 02 Jun 2023 at Happicare Curated Health Private Limited.

The 2 current companies of Nanjesh Niranjan Swamy that report revenue have a combined latest revenue of ₹4.66 Cr: Behandeln Medcare Solutions Private Limited ₹4.65 Cr (FY 2020); Attentionkart Private Limited ₹1.3 Lakh (FY 2025).

Nanjesh Niranjan Swamy held 1 earlier board appointment: Enkefalos Technologies Llp (Designated Partner, 21 Oct 2020 to 10 Jul 2023).

The current boards of Nanjesh Niranjan Swamy's companies include Krishna Muthagere Raghavan (Behandeln Medcare Solutions Private Limited), Shiraz Ahmed Nisar (Behandeln Medcare Solutions Private Limited), Sinu George (Behandeln Medcare Solutions Private Limited), Girish Ranjana (Attentionkart Private Limited), Trilok Chander Kunchakarra (Attentionkart Private Limited), Nirmal (Happicare Curated Health Private Limited), among others.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available